Loading...
Market
What will be the outcome of investigations into estrogen therapy safety by end of 2025?
2
Resolution / Starting Odds
Link confirmed • 25%
Link disproven • 25%
Inconclusive • 25%
No investigation • 25%
Publication of investigation results by a recognized health organization or medical journal
Story
Report Links Estrogen Hormone Therapy to Thyroid Cancer in Three Transgender Veterans
Oct 16, 2024, 04:10 PM
A recent report has linked hormone replacement therapy, specifically estrogen, to the development of thyroid cancer in three transgender military veterans. All three individuals, born male and identifying as female, underwent hormone therapy and subsequently were diagnosed with cancer. Medical professionals treating these patients noted that it is 'conceivable' that the hormone therapy could have contributed to their conditions, referencing previous research that associates estrogen with tumor growth. The report has prompted calls from doctors for further investigation into the safety of hormone treatments for transgender individuals.
View original story
Similar markets
No issues found • 25%
Minor issues found • 25%
Significant issues found • 25%
Undetermined • 25%
No changes recommended • 25%
Some vaccines recommended for elimination • 25%
Enhanced safety protocols recommended • 25%
Comprehensive overhaul of vaccine policies • 25%
Confirms higher SAE rate in early batches • 25%
Confirms no difference in SAE rates • 25%
Finds other contributing factors • 25%
Inconclusive results • 25%
No Action Taken • 25%
Publication Mandated • 25%
Funding Reallocation • 25%
Other Outcome • 25%
No issues found • 25%
Minor issues found • 25%
Moderate issues found • 25%
Severe issues found • 25%
Revised guidelines • 25%
Increased studies • 25%
No change • 25%
Other actions • 25%
Clinics cleared of wrongdoing • 25%
Clinics face fines • 25%
Clinics face license suspensions • 25%
Clinics face criminal charges • 25%
Study published without consequences • 25%
Study published with consequences for Dr. Olson-Kennedy • 25%
Study remains unpublished • 25%
Other outcome • 25%
No link found • 25%
Link found • 25%
Inconclusive results • 25%
Investigation not completed • 25%
No evidence found • 25%
Some evidence found • 25%
Significant evidence found • 25%
Inconclusive • 25%
Yes • 50%
No • 50%
Safety concerns resolved • 25%
Further investigation required • 25%
Vaccine trials permanently halted • 25%
Other outcome • 25%